Affiliations 

  • 1 Marhanis Salihah Omar, Faculty of Pharmacy,, Universiti Kebangsaan Malaysia,, Jalan Raja Muda Abdul Aziz,, Kuala Lumpur 50300, Malaysia, marha.nis@ukm.edu.my, ORCID: http://orcid.org/0000-0002-0290-9424
Ann Saudi Med, 2018 8 6;38(4):269-276.
PMID: 30078025 DOI: 10.5144/0256-4947.2018.269

Abstract

BACKGROUND: Contrast-induced acute kidney injury (CI-AKI) is rec.ognized as a common complication of radiographic contrast-enhanced procedures. N-acetylcysteine (NAC) is commonly prescribed, but CI-AKI can still develop despite NAC administration as prophylaxis.

OBJECTIVE: Identify the predictive factors for development of CI-AKI in patients prescribed NAC.

DESIGN: Prospective, cross-sectional.

SETTING: A tertiary hospital in Malaysia.

PATIENTS AND METHODS: All adult patients who were prescribed NAC for prevention of CI-AKI were identified through an NAC drug us.age monitoring card maintained by the inpatient pharmacy. The study was conducted from March to July 2017.

MAIN OUTCOME MEASURES: Statistically significant predictive fac.tors for development of CI-AKI despite NAC administration.

SAMPLE SIZE: 152 RESULTS: The most commonly recognized risk factors for CI-AKI present in the study population were renal impairment (n=131, 86.2%), anemia (n=107, 70.4%), and diabetes mellitus (n=90, 59.2%). Hydration therapy was initiated in 128 patients (84.2%) prior to the contrast-enhanced procedure. Sixty-one (40.1%) were treated with nephrotoxic medications concomitantly with NAC. Fifteen (9.9%) patients developed AKI. Hypotension (OR: 6.02; 95% CI 1.25-28.97) and use of high contrast volume (OR: 6.56; 95% CI: 1.41-30.64) significantly increased the odds for AKI. Prior hydration therapy (OR: 0.13; 95% CI 0.03-0.59) showed protective effects.

CONCLUSION: The risk predictors identified for CI-AKI were hypotension, high contrast volume and prior hydration therapy.

LIMITATION: May not have identified other confounding factors for development of CI-AKI.

CONFLICT OF INTEREST: None.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.